Literature DB >> 14611721

COX-2 selective inhibitors and bone.

S B Goodman1, T Ma, M Genovese, R Lane Smith.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed medications for relief of pain and inflammation. Recent animal studies using models of fracture healing and bone ingrowth suggest that NSAIDs (both non-selective NSAIDs and selective COX-2 inhibitors) adversely affect these bone-related processes. The dose and time-relationships of these medications and their resulting effects on bone have not yet been fully elucidated. Furthermore, whether COX-2 inhibitors and non-selective NSAIDs lead to clinically relevant adverse effects on bone healing in humans is unknown.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611721     DOI: 10.1177/039463200301600303

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  4 in total

1.  How Do Drugs Affect the Skeleton? Implications for Forensic Anthropology.

Authors:  Nicholas Márquez-Grant; Elisa Baldini; Victoria Jeynes; Lucie Biehler-Gomez; Layla Aoukhiyad; Nicholas V Passalacqua; Gaia Giordano; Domenico Di Candia; Cristina Cattaneo
Journal:  Biology (Basel)       Date:  2022-03-29

2.  Use of imatinib in the prevention of heterotopic ossification.

Authors:  Clément M L Werner; Stefan M Zimmermann; Carola C Würgler-Hauri; Joseph M Lane; Guido A Wanner; Hans-Peter Simmen
Journal:  HSS J       Date:  2013-06-21

3.  EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.

Authors:  Minjie Zhang; Hsin-chiu Ho; Tzong-jen Sheu; Matthew D Breyer; Lisa M Flick; Jennifer H Jonason; Hani A Awad; Edward M Schwarz; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2011-04       Impact factor: 6.741

4.  Cross-species comparisons reveal resistance of human skeletal stem cells to inhibition by non-steroidal anti-inflammatory drugs.

Authors:  L Henry Goodnough; Thomas H Ambrosi; Holly M Steininger; M Gohazrua K Butler; Malachia Y Hoover; HyeRan Choo; Noelle L Van Rysselberghe; Michael J Bellino; Julius A Bishop; Michael J Gardner; Charles K F Chan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.